InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Requadt Scott, Chairman & CEO. Officer active across 1 companies, notably Talaris Therapeutics, Inc.. In total, 2 disclosures have been logged. The latest transaction was filed on 31 December 2021 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€16,8741,470 shares@ €11.479100.0% of flow
Common Stock
SEC:0000899243-22-004202·
€16,8741,470 shares@ €11.47950.0% of flow
Common Stock
SEC:0000899243-22-004202:0·
2 of 2 declarations
About Requadt Scott
Scott Requadt is the Chief Executive Officer of Talaris Therapeutics, Inc. He oversees the company's operations and is responsible for the overall strategy. His experience in the biopharmaceutical sector enables him to effectively lead Talaris towards innovation and growth.
